Free Trial

ResMed (RMD) Short Interest Ratio & Short Volume

$207.17
-6.09 (-2.86%)
(As of 05/28/2024 ET)

ResMed Short Interest Data

Current Short Interest
10,210,000 shares
Previous Short Interest
9,850,000 shares
Change Vs. Previous Month
+3.65%
Dollar Volume Sold Short
$2.25 billion
Short Interest Ratio
9.5 Days to Cover
Last Record Date
May 15, 2024
Outstanding Shares
146,910,000 shares
Percentage of Shares Shorted
6.95%
Today's Trading Volume
810,821 shares
Average Trading Volume
1,016,997 shares
Today's Volume Vs. Average
80%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling ResMed ?

Sign up to receive the latest short interest report for ResMed and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

RMD Short Interest Over Time

RMD Days to Cover Over Time

RMD Percentage of Float Shorted Over Time

ResMed Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
5/15/202410,210,000 shares $2.25 billion +3.7%N/A9.5 $220.63
4/30/20249,850,000 shares $2.11 billion +23.9%N/A9 $214.04
4/15/20247,950,000 shares $1.47 billion +0.8%N/A7.5 $185.09
3/31/20247,890,000 shares $1.56 billion +3.0%N/A7.8 $198.03
3/15/20247,660,000 shares $1.46 billion +13.3%N/A7.9 $190.10
2/29/20246,760,000 shares $1.17 billion +2.7%N/A7.4 $173.72
2/15/20246,580,000 shares $1.20 billion +4.0%N/A7.4 $182.64
1/31/20246,330,000 shares $1.20 billion +7.5%N/A6.5 $190.20
1/15/20245,890,000 shares $1.02 billion +3.9%N/A5.5 $173.90
12/31/20235,670,000 shares $975.35 million -2.4%N/A4.8 $172.02
12/15/20235,810,000 shares $982.18 million -0.7%N/A4.4 $169.05
11/30/20235,850,000 shares $922.72 million -7.3%N/A3.9 $157.73
11/15/20236,310,000 shares $960.07 million +10.3%N/A3.9 $152.15
10/31/20235,720,000 shares $807.78 million +18.4%N/A3.3 $141.22
10/15/20234,830,000 shares $677.41 million +1.5%N/A2.9 $140.25
9/30/20234,760,000 shares $703.86 million +24.6%N/A3.2 $147.87
9/15/20233,820,000 shares $555.39 million +20.9%N/A2.9 $145.39
8/31/20233,160,000 shares $504.30 million +110.7%N/A2.8 $159.59
8/15/20231,500,000 shares $275.03 million +19.1%N/A1.6 $183.35
7/31/20231,260,000 shares $280.16 million -5.3%N/A1.7 $222.35
7/15/20231,330,000 shares $295.73 million +11.8%N/A2.1 $222.35
6/30/20231,190,000 shares $260.02 million +15.5%N/A1.9 $218.50
6/15/20231,030,000 shares $225.42 million -28.5%N/A1.7 $218.85
5/31/20231,440,000 shares $303.54 million +38.5%N/A2.4 $210.79
5/15/20231,040,000 shares $241.79 million +2.0%N/A1.9 $232.49
4/30/20231,020,000 shares $245.78 million -11.3%N/A1.8 $240.96
4/15/20231,150,000 shares $258.24 million -19.0%N/A2 $224.56
3/31/20231,420,000 shares $310.97 million +9.2%1.0%2.3 $218.99
3/15/20231,300,000 shares $270.39 million +20.4%0.9%2 $207.99
2/28/20231,080,000 shares $230.04 million +1.9%0.7%1.7 $213.00
2/15/20231,060,000 shares $227.77 million +25.5%0.7%1.7 $214.88
1/31/2023844,900 shares $192.95 million -0.6%0.6%1.5 $228.37
1/15/2023850,000 shares $185.39 million -15.8%0.6%1.5 $218.10
12/30/20221,010,000 shares $210.21 million +6.3%0.7%1.8 $208.13
12/15/2022950,100 shares $204.31 million -5.9%0.7%1.8 $215.04
11/30/20221,010,000 shares $232.50 million -5.6%0.7%2 $230.20
11/15/20221,070,000 shares $239.28 million -18.3%0.7%2.2 $223.63
10/31/20221,310,000 shares $293.03 million +6.5%0.9%2.6 $223.69
10/15/20221,230,000 shares $260.45 million -8.2%0.9%2.6 $211.75
9/30/20221,340,000 shares $292.52 million -11.3%0.9%2.9 $218.30
Must-See: Elon’s New Invention is Absolutely Insane (Ad)

Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street veteran, Eric Fry… This mind-blowing new technology could be bigger than the iPhone.

Click here for the full story…
9/15/20221,510,000 shares $341.18 million +18.0%1.0%3 $225.95
8/31/20221,280,000 shares $281.50 million -3.0%0.9%2.3 $219.92
8/15/20221,320,000 shares $312.99 million -28.3%0.9%2.4 $237.11
7/31/20221,840,000 shares $442.56 million +18.7%1.3%3.2 $240.52
7/15/20221,550,000 shares $349.53 million +11.5%1.1%2.5 $225.50
6/30/20221,390,000 shares $291.39 million -7.3%1.0%2.3 $209.63
6/15/20221,500,000 shares $304.92 million +15.4%1.0%2.5 $203.28
5/31/20221,300,000 shares $264.50 million -4.4%0.9%2.4 $203.46
5/15/20221,360,000 shares $267.73 million +5.4%0.9%2.4 $196.86
4/30/20221,290,000 shares $257.96 million -1.5%0.9%2.2 $199.97
4/15/20221,310,000 shares $306.82 million +6.5%0.9%2.2 $234.21
3/31/20221,230,000 shares $298.29 million +27.8%0.9%2 $242.51
3/15/2022962,200 shares $235.08 million -16.3%0.7%1.7 $244.31
2/28/20221,150,000 shares $283.76 million -8.0%0.8%2 $246.75
2/15/20221,250,000 shares $294.06 million +44.3%0.9%2.2 $235.25
1/31/2022866,400 shares $198.06 million +9.7%0.6%1.6 $228.60
1/15/2022790,100 shares $199.23 million +3.6%0.6%1.6 $252.16
12/31/2021762,800 shares $198.69 million +3.2%0.5%1.5 $260.48
12/15/2021739,000 shares $189.60 million -13.1%0.5%1.3 $256.56
11/30/2021850,600 shares $216.78 million -8.0%0.6%1.5 $254.85
11/15/2021924,400 shares $242.53 million -11.1%0.6%1.7 $262.37
10/29/20211,040,000 shares $273.43 million +8.8%0.7%2 $262.91
10/15/2021955,600 shares $244.15 million -2.5%0.7%1.9 $255.49
9/30/2021979,800 shares $258.23 million -10.1%0.7%2.1 $263.55
9/15/20211,090,000 shares $316.56 million No Change0.8%2.3 $290.42
8/31/20211,090,000 shares $316.68 million -11.4%0.8%2.1 $290.53
8/13/20211,230,000 shares $338.37 million +16.0%0.9%2.2 $275.10
7/30/20211,060,000 shares $288.11 million No Change0.7%1.8 $271.80
7/15/20211,060,000 shares $264.58 million -10.2%0.7%1.7 $249.60
6/30/20211,180,000 shares $290.89 million -16.3%0.8%1.9 $246.52
6/15/20211,410,000 shares $333.41 million -0.7%1.0%2.2 $236.46
5/28/20211,420,000 shares $292.31 million -9.0%1.0%2.4 $205.85
5/14/20211,560,000 shares $303.98 million +40.5%N/A2.5 $194.86
4/30/20211,110,000 shares $230.78 million -2.6%N/A1.6 $207.91
4/15/20211,140,000 shares $236.76 million +17.2%N/A1.7 $207.68
3/31/2021972,500 shares $184.10 million +5.6%N/A1.5 $189.31
3/15/2021920,600 shares $170.42 million -9.8%N/A1.4 $185.12
2/26/20211,020,000 shares $198.88 million -14.3%N/A1.7 $194.98
2/12/20211,190,000 shares $238.63 million +9.2%N/A2.1 $200.53
1/29/20211,090,000 shares $235.36 million +0.9%N/A2.1 $215.93
1/15/20211,080,000 shares $230.34 million No ChangeN/A2.3 $213.28
12/31/20201,080,000 shares $226.50 million -4.4%N/A2.3 $209.72
12/15/20201,130,000 shares $233.21 million -3.4%N/A2.3 $206.38
11/30/20201,170,000 shares $245.28 million -20.4%N/A2.3 $209.64
11/15/20201,470,000 shares $315.67 million +9.7%N/A2.9 $214.74
10/30/20201,340,000 shares $240.54 million -8.8%N/A2.4 $179.51
10/15/20201,470,000 shares $261.38 million -3.3%N/A2.5 $177.81
9/30/20201,520,000 shares $260.57 million +2.7%N/A2.6 $171.43
9/15/20201,480,000 shares $259.81 million -11.4%N/A2.4 $175.55
8/31/20201,670,000 shares $301.90 million +3.7%N/A2.5 $180.78
Must-See: Elon’s New Invention is Absolutely Insane (Ad)

Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street veteran, Eric Fry… This mind-blowing new technology could be bigger than the iPhone.

Click here for the full story…
8/14/20201,610,000 shares $284.62 million -9.0%N/A2.3 $176.78
7/31/20201,770,000 shares $358.44 million +0.6%N/A2.6 $202.51
7/15/20201,760,000 shares $343.27 million -18.1%N/A2.6 $195.04
6/30/20202,150,000 shares $412.80 million +54.7%N/A3.1 $192.00
6/15/20201,390,000 shares $223.36 million -18.2%N/A1.9 $160.69
5/29/20201,700,000 shares $273.39 million -11.0%N/A2 $160.82
5/15/20201,910,000 shares $313.47 million +22.4%N/A2.2 $164.12
4/30/20201,560,000 shares $242.30 million -14.3%N/A1.8 $155.32
4/15/20201,820,000 shares $291.51 million +6.4%1.3%2.2 $160.17
3/31/20201,710,000 shares $275.31 million -8.6%1.2%2.1 $161.00
3/13/20201,871,400 shares $299.09 million -16.5%N/A3.4 $159.82
2/28/20202,240,000 shares $271.85 million -5.5%1.6%4.1 $121.36
2/14/20202,370,000 shares $383.25 million +10.8%1.7%4.7 $161.71
1/31/20202,140,000 shares $355.07 million -1.4%1.5%4.3 $165.92
1/15/20202,170,000 shares $378.34 million -4.0%1.5%4.3 $174.35
12/31/20192,260,000 shares $367.00 million +0.9%1.6%4.6 $162.39
8/15/20192,353,800 shares $318.05 million +2.3%1.7%4.4 $135.12

RMD Short Interest - Frequently Asked Questions

What is ResMed's current short interest?

Short interest is the volume of ResMed shares that have been sold short but have not yet been closed out or covered. As of May 15th, traders have sold 10,210,000 shares of RMD short. Learn More on ResMed's current short interest.

What is a good short interest ratio for ResMed?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. RMD shares currently have a short interest ratio of 10.0. Learn More on ResMed's short interest ratio.

Which institutional investors are shorting ResMed?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of ResMed: Walleye Trading LLC, Jane Street Group LLC, PEAK6 Investments LLC, Capstone Investment Advisors LLC, Concourse Financial Group Securities Inc., and Caas Capital Management LP. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Is ResMed's short interest increasing or decreasing?

ResMed saw a increase in short interest in May. As of May 15th, there was short interest totaling 10,210,000 shares, an increase of 3.7% from the previous total of 9,850,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does ResMed's short interest compare to its competitors?

Here is how the short interest of companies in the sector of "medical" compare to ResMed: Baxter International Inc. (1.56%), Insulet Co. (6.08%), DexCom, Inc. (1.96%), Teleflex Incorporated (1.84%), Globus Medical, Inc. (5.30%), Becton, Dickinson and Company (0.68%), Boston Scientific Co. (0.84%), Stryker Co. (1.15%), West Pharmaceutical Services, Inc. (1.57%), Shockwave Medical, Inc. (4.87%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.81 billion), Charter Communications, Inc. ($3.30 billion), Occidental Petroleum Co. ($3.10 billion), General Motors ($2.84 billion), Moderna, Inc. ($2.77 billion), AppLovin Co. ($2.22 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.16 billion), Tractor Supply ($2.12 billion), and Williams-Sonoma, Inc. ($2.12 billion). View all of the most shorted stocks.

What does it mean to sell short ResMed stock?

Short selling RMD is an investing strategy that aims to generate trading profit from ResMed as its price is falling. RMD shares are trading down $6.09 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against ResMed?

A short squeeze for ResMed occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of RMD, which in turn drives the price of the stock up even further.

How often is ResMed's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including RMD, twice per month. The most recent reporting period available is May, 15 2024.



More Short Interest Resources from MarketBeat

This page (NYSE:RMD) was last updated on 5/28/2024 by MarketBeat.com Staff

From Our Partners